Pfizer Inc. PFE shares are trading lower by about half a percent on Monday as investors digest a leadership transition in the finance seat. Here’s what investors need to know. Pfizer stock is taking a ...
Investors should always consider the long game when looking at stocks. Even if a business is not doing well right now, that doesn't mean it'll always be the case. Looking at a broader time frame can ...
Pfizer Inc. PFE shares are trading flat during Wednesday’s premarket session as traders weigh mixed Phase 3 trial headlines ...
Get the live share price of Pfizer Inc (PFE), including intraday charts, historical performance, key financials, and market ...
Pfizer is drawing renewed market attention as healthcare strength, pharmaceutical deal activity, and defensive demand reshape ...
I last covered Pfizer Inc. stock (NYSE:PFE) on Feb 19. The article rated the stock as hold after examining its FQ4 earnings report (ER) and dividend declarations. Since then, a few new catalysts have ...
AbbVie focuses on specialized therapies in immunology, oncology, and neuroscience. The company sells these treatments globally, relying heavily on three major wholesale distributors: McKesson ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Pfizer offers a 6.3% yield, but its high dividend reflects weak growth prospects and looming patent cliffs. PFE’s dividend is currently covered by cash flow, but payout ratios are stretched, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results